Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Antimony sodium tartrate [USP:JAN]
RN: 34521-09-0
UNII: 3KUI0LP48L
InChIKey: UZVPADYOEPQJSP-SOMOIXMJSA-J

Classification Codes

  • Antischistosomal
  • Drug / Therapeutic Agent
  • Human Data
  • Mutation Data

Molecular Formulas

  • C8-H4-Na2-O12-Sb2
  • C8-H4-O12-Sb2.2Na

Molecular Weight

  • 581.6076
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Antimony sodium tartrate
  • Antimony sodium tartrate [USP:JAN]

Synonyms

  • Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O(sup 1),O(sup 2):O(sup 3),O(sup 4)))di-, disodium, stereoisomer
  • Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4))di-, disodium, stereoisomer
  • Antimony sodium oxide L-(+)-tartrate
  • Antimony sodium tartrate
  • Antimonyl sodium tartrate
  • Diantimony ditartrate disodium
  • Disodium bis(mu-(L-(+)-tartrato(4-)))diantimonate(2-)
  • EINECS 252-070-9
  • Emetosodium
  • Natriumantimonyltartrat
  • Natriumantimonyltartrat [German]
  • Sodium antimony tartrate
  • Sodium antimonyl tartrate
  • sodium tartar emetic
  • Stibnal
  • UNII-3KUI0LP48L

Systematic Names

  • Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O(sup 1),O(sup 2):O(sup 3),O(sup 4)))di-, disodium, stereoisomer
  • Antimony sodium tartrate

Registry Numbers

CAS Registry Number

  • 34521-09-0

FDA UNII

  • 3KUI0LP48L

Related Registry Number

  • 12544-35-3 (Parent)

System Generated Number

  • 0034521090

Molecular Formulas

Molecular Formulas

  • C8-H4-Na2-O12-Sb2
  • C8-H4-O12-Sb2.2Na

Molecular Formula Fragments

  • C8-H4-O12-Sb2
  • COMPONENT
  • Na

Structure Descriptors

InChI

1S/2C4H4O6.2Na.2Sb/c2*5-1(3(7)8)2(6)4(9)10;;;;/h2*1-2H,(H,7,8)(H,9,10);;;;/q2*-2;2*+1;2*+3/p-4/t2*1-,2-;;;;/m11..../s1

InChIKey

UZVPADYOEPQJSP-SOMOIXMJSA-J

Smiles

[Na+].[Na+].[O-]C(=O)[C@@H]1O[Sb]2O[C@H]([C@@H](O[Sb]3O[C@H]1C(=O)O3)C(=O)[O-])C(=O)O2

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo intravenous 79mg/kg/3D-I (79mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: HEADACHE

GASTROINTESTINAL: NAUSEA OR VOMITING
Terapevticheskii Archiv. Archives of Therapeutics. Vol. 34(4), Pg. 62, 1962.
mouse LD50 intraperitoneal 60mg/kg (60mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: MUSCLE WEAKNESS
Proceedings of the Society for Experimental Biology and Medicine. Vol. 129, Pg. 284, 1968.
mouse LD50 intravenous 25mg/kg (25mg/kg)   Merck Index. Vol. 10, Pg. 103, 1983.
mouse LD50 subcutaneous 48mg/kg (48mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Proceedings of the Society for Experimental Biology and Medicine. Vol. 129, Pg. 284, 1968.